Publications:

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report.

Jto Clinical And Research Reports

Enrico, Diego D; Lacroix, Ludovic L; Chen, Jeanne J; Rouleau, Etienne E; Scoazec, Jean-Yves JY; Loriot, Yohann Y; Tselikas, Lambros L; Jovelet, Cécile C; Planchard, David D; Gazzah, Anas A; Mezquita, Laura L; Ngo-Camus, Maud M; Michiels, Stefan S; Massard, Christophe C; Recondo, Gonzalo G; Facchinetti, Francesco F; Remon, Jordi J; Soria, Jean-Charles JC; André, Fabrice F; Vassal, Gilles G; Friboulet, Luc L; Besse, Benjamin B

Publication Date: 2020-06

Variant appearance in text: EGFR: I706Y

PubMed Link: 34589930

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page